Acute leukemia in Malaysian children.
A review of acute childhood leukemia in the University Hospital, Kuala Lumpur reveals no significant differences in either the epidemiological or clinical features between Malaysian and Caucasian children. BCG does not appear to have conferred any protection against the occurrence of leukemia. With the introduction of total therapy 4 of 10 patients with good prognostic features and 3 of 15 patients with poor prognostic features have survived 3 years. Prognosis appears to correlate with adopted clinical criteria.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D044466:Asian People; D001500:BCG Vaccine / Q000494:pharmacology; D001853:Bone Marrow / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000473:pathology / Q000517:prevention & control; D008296:Malaysia; D008297:Male; D011379:Prognosis; D012075:Remission, Spontaneous; D013997:Time Factors; D044465:White People
D000970:Antineoplastic Agents; D001500:BCG Vaccine